clinical trial · NCT04174170
Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc.·phase3·completed·n = 591
Post Traumatic Stress DisorderBrexpiprazoleSertralinePlaceboBrexpiprazole
brief summary
This will be a 12-week, multicenter, randomized, double-blind trial evaluating the efficacy, safety, and tolerability of fixed-dose brexpiprazole + sertraline combination treatment in adult subjects with post-traumatic stress disorder.
started
Oct 30, 2019
primary completion
Jul 25, 2023
completion
Aug 15, 2023
last updated
May 30, 2025
official title
A Phase 3, Multicenter, Randomized, Double-blind Trial of Fixed-Dose Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol